Marvellous Medicine
Analysis14 Jun 2021

Marvellous Medicine

Most of us were blindsided by the novel virus SarsCov2, but infectious disease experts had been warning about the possibility of a global pandemic for some years. For them it was never a matter of if, but when. What did come as a surprise was the speed of scientific progress to fight Covid 19. The first effective vaccine, from Pfizer/BioNTech, was developed in under 300 days, followed in successive weeks by Moderna and Oxford/AstraZeneca. The results of the UK’s RECOVERY trial, which was organised in a matter of weeks, has saved an estimated million lives worldwide by identifying which treatments are effective in treating Covid 19. And regulators around the globe, like Britain’s MHRA, are using innovative programmes to get medical products to people faster. During the pandemic, the world witnessed how fast medicine can advance with an abundance of cash and collaboration. Is progress at this speed and cost sustainable? Sandra Kanthal asks if drug development is something which should still take decades, or have we learned how to permanently accelerate the process?

Guests:

Rod MacKenzie, Chief Development Officer, Pfizer Nuala Murphy, President Clinical Research Services, Icon Professor Sir Martin Landray, Co-Chief Investigator, RECOVERY Trial Nicholas Jackson, Head of Programmes and Technology, CEPI Christian Schneider, Interim Chief Scientific Officer, MHRA Hilda Bastian, Independent Scientist

Producer and Presenter Sandra Kanthal Editor Jasper Corbett

Episoder(389)

Meet the Family

Meet the Family

Politicians love talking about supporting families. But, asks Jo Fidgen, do they understand modern family life? And how far can or should the state change the way families live? There's endless focus ...

13 Okt 201427min

Peston and the House of Debt

Peston and the House of Debt

Robert Peston tests the arguments made by the authors of a new book who claim the financial crisis was caused by exploding household debt - not by the banks. But are they right?Now the BBC's Economics...

6 Okt 201428min

Michael Pollan on Food

Michael Pollan on Food

What should we eat? Jo Fidgen talks to the influential American writer Michael Pollan about what food is - and what it isn't. In an interview before an audience at the London School of Economics and P...

29 Sep 201427min

Thrifty Debtors

Thrifty Debtors

The downturn's made everyone worry more about money. But while we may want to be thriftier, Chris Bowlby discovers why we're stuck with high levels of personal and household debt. Credit has become a ...

21 Jul 201427min

The End of the Pay Rise?

The End of the Pay Rise?

Something strange has been happening in the British economy. For over six years now, wages have fallen for most of us, which is unprecedented in British modern history. And despite the return of econo...

14 Jul 201428min

Tories: Nasty or Nice?

Tories: Nasty or Nice?

Why have the Tories attracted the label 'the nasty party'? Tory supporter Robin Aitken explores why the phrase took hold, and why it matters in key national debates today. Senior and influential figur...

30 Jun 201427min

Varieties of Capitalism

Varieties of Capitalism

What is the best form of capitalism? The free-market form found in countries such as the UK and the United States, or the more collaborative model which is common across Northern Europe?Some British p...

23 Jun 201427min

What Does Putin Want?

What Does Putin Want?

There's a new government in Kiev and Crimea is firmly in Russian hands. The political map of eastern Europe has changed dramatically in the last few months. But are Moscow's actions in the Ukraine cri...

9 Jun 201428min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden-usa
aftenpodden
i-retten
forklart
stopp-verden
popradet
fotballpodden-2
rss-gukild-johaug
nokon-ma-ga
det-store-bildet
dine-penger-pengeradet
bt-dokumentar-2
aftenbla-bla
hanna-de-heldige
rss-penger-polser-og-politikk
rss-dannet-uten-piano
frokostshowet-pa-p5
rss-ness
e24-podden